Baillie Gifford and ORI Capital co-led the financing with significant new investments from Temasek and Cowen Healthcare Investments, alongside Juda Capital, Pavilion Capital, RTW Investments, Agent Capital, 4BIO Capital and existing investors F-Prime Capital and […]
Development work will now start on the construction of the dedicated bioconjugation facility at the company’s new site in Deeside, North Wales, UK. The contract follows the announcement in September of ADC Bio securing $11 […]
JHL Biotech (Stock Code: 6540.TWO) announced today that it has submitted a Phase 1 Clinical Trial Application to the Dutch Healthcare Authority for its proposed dornase alfa biosimilar, JHL1922, to improve pulmonary function in cystic […]
The collaboration will further both companies’ shared mission of transforming clinical trials by expanding access to patient data analytics services. Members of the BlueCloud Sponsor Network will be able to view the locations and numbers […]
In Singapore, this multi-institutional effort involves A*STAR’s Genome Institute of Singapore (GIS) and Institute of Molecular and Cell Biology (IMCB), National Cancer Centre Singapore (NCCS), and National University of Singapore (NUS). HCC is the second […]